vida: research 2026 04 29 #5970

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 10:38:37 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 10:38 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 10:38 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific data points and expert opinions from the linked sources, such as the MSSP savings figures and GLP-1 coverage decline.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is presented uniquely within the research journal.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the new quantitative data from MSSP and the analysis of market competition mechanisms provide strong support for strengthening the belief.
  4. Wiki links — There are no explicit wiki links in the research-journal.md file to check for brokenness.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific data points and expert opinions from the linked sources, such as the MSSP savings figures and GLP-1 coverage decline. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is presented uniquely within the research journal. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the new quantitative data from MSSP and the analysis of market competition mechanisms provide strong support for strengthening the belief. 4. **Wiki links** — There are no explicit wiki links in the `research-journal.md` file to check for brokenness. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Session 2026-04-29 Research Journal Entry

Criterion-by-Criterion Evaluation

  1. Schema — All files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal is a narrative document without frontmatter requirements, so schema compliance is satisfied for all file types present.

  2. Duplicate/redundancy — This is a research journal entry synthesizing multiple sources into a single narrative session; no individual claims are being enriched in this PR, so there is no risk of injecting duplicate evidence into existing claims (the journal entry references future enrichment needs but doesn't perform them here).

  3. Confidence — No claim files are modified in this PR (only journal entries and source files added to inbox/queue/), so there are no confidence levels to evaluate.

  4. Wiki links — The journal entry contains no wiki links to check, so this criterion is not applicable to the current PR content.

  5. Source quality — The sources cited include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, industry newsletters (9amHealth, HCPlan), and expert commentary (Waltz on Lilly DTE), which collectively provide credible evidence for healthcare payment reform and market competition analysis.

  6. Specificity — This is a research journal entry (not a claim file), so the specificity criterion for falsifiable propositions does not apply; the entry documents a disconfirmation attempt with specific quantitative findings ($2.48B MSSP savings, 7%→14% capitation growth, 3.6M→2.8M GLP-1 covered lives) that would inform future claim creation.

Verdict Justification

This PR adds a research journal session and supporting source files to the inbox. No claims are being created or modified, so the primary risk vectors (confidence miscalibration, title overclaims, factual discrepancies in claim files) are not present. The journal entry demonstrates rigorous disconfirmation methodology with specific quantitative evidence from credible sources. The sources themselves (CMS reports, Health Affairs, industry analysis) meet quality standards for healthcare policy research.

# PR Review: Session 2026-04-29 Research Journal Entry ## Criterion-by-Criterion Evaluation 1. **Schema** — All files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal is a narrative document without frontmatter requirements, so schema compliance is satisfied for all file types present. 2. **Duplicate/redundancy** — This is a research journal entry synthesizing multiple sources into a single narrative session; no individual claims are being enriched in this PR, so there is no risk of injecting duplicate evidence into existing claims (the journal entry references future enrichment needs but doesn't perform them here). 3. **Confidence** — No claim files are modified in this PR (only journal entries and source files added to inbox/queue/), so there are no confidence levels to evaluate. 4. **Wiki links** — The journal entry contains no [[wiki links]] to check, so this criterion is not applicable to the current PR content. 5. **Source quality** — The sources cited include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, industry newsletters (9amHealth, HCPlan), and expert commentary (Waltz on Lilly DTE), which collectively provide credible evidence for healthcare payment reform and market competition analysis. 6. **Specificity** — This is a research journal entry (not a claim file), so the specificity criterion for falsifiable propositions does not apply; the entry documents a disconfirmation attempt with specific quantitative findings ($2.48B MSSP savings, 7%→14% capitation growth, 3.6M→2.8M GLP-1 covered lives) that would inform future claim creation. ## Verdict Justification This PR adds a research journal session and supporting source files to the inbox. No claims are being created or modified, so the primary risk vectors (confidence miscalibration, title overclaims, factual discrepancies in claim files) are not present. The journal entry demonstrates rigorous disconfirmation methodology with specific quantitative evidence from credible sources. The sources themselves (CMS reports, Health Affairs, industry analysis) meet quality standards for healthcare policy research. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 10:40:15 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 10:40:15 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 10:42:42 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.